Patents by Inventor Thomas M. Ashley

Thomas M. Ashley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030191149
    Abstract: The present invention provides for methods for the treatment of fibromyalgia syndrome or chronic fatigue syndrome by the administration of heterocyclic amine-type compounds, substituted phenylazacycloalkane-type compounds, or cabergoline-type compounds, or a salt of any said compound.
    Type: Application
    Filed: March 7, 2003
    Publication date: October 9, 2003
    Inventors: Robert B. McCall, Robert Clyde Marshall, David W. Robertson, Thomas M. Ashley
  • Patent number: 6555548
    Abstract: The present invention provides for methods for the treatment of fibromyalgia syndrome or chronic fatigue syndrome by the administration of cabergoline-type compounds or a salt of said compound.
    Type: Grant
    Filed: May 30, 2002
    Date of Patent: April 29, 2003
    Assignee: Pharmacia & Upjohn Company
    Inventors: Robert B. McCall, Robert Clyde Marshall, David W. Robertson, Thomas M. Ashley
  • Publication number: 20020143010
    Abstract: The present invention provides for methods for the treatment of fibromyalgia syndrome or chronic fatigue syndrome by the administration of heterocyclic amine-type compounds, substituted phenylazacycloalkane-type compounds, or cabergoline-type compounds, or a salt of any said compound.
    Type: Application
    Filed: May 30, 2002
    Publication date: October 3, 2002
    Inventors: Robert B. McCall, Robert Clyde Marshall, David W. Robertson, Thomas M. Ashley
  • Patent number: 6448258
    Abstract: The present invention provides for methods for the treatment of fibromyalgia syndrome or chronic fatigue syndrome by the administration of heterocyclic amine-type compounds or a salt of any said compound.
    Type: Grant
    Filed: April 17, 2001
    Date of Patent: September 10, 2002
    Assignee: Pharmacia & Upjohn Company
    Inventors: Robert B. McCall, Robert Clyde Marshall, David W. Robertson, Thomas M. Ashley
  • Publication number: 20020004510
    Abstract: The present invention provides for methods for the treatment of fibromyalgia syndrome or chronic fatigue syndrome by the administration of heterocyclic amine-type compounds, substituted phenylazacycloalkane-type compounds, or cabergoline-type compounds, or a salt of any said compound.
    Type: Application
    Filed: April 17, 2001
    Publication date: January 10, 2002
    Inventors: Robert B. McCall, Robert Clyde Marshall, David W. Robertson, Thomas M. Ashley